Assembly Biosciences, Inc. (ASMB)
31.95
-1.37
(-4.11%)
USD |
NASDAQ |
Dec 30, 14:45
Assembly Biosciences EPS Diluted (Quarterly): -0.7249 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 2.434 |
| CorMedix, Inc. | 1.259 |
| Supernus Pharmaceuticals, Inc. | -0.7978 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.196M |
| Revenue (Quarterly) | 10.79M |
| Total Expenses (Quarterly) | 19.98M |
| Enterprise Value | 297.22M |
| Gross Profit Margin (Quarterly) | 99.70% |
| Profit Margin (Quarterly) | -85.24% |
| Earnings Yield | -15.03% |
| Normalized Earnings Yield | -15.03 |